Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
synthetic cannabinoid
|
| gptkbp:actsOn |
cannabinoid receptor agonist
|
| gptkbp:binds |
gptkb:CB1_receptor
gptkb:CB2_receptor |
| gptkbp:CASNumber |
83002-04-4
|
| gptkbp:chemicalFormula |
C24H52O2
|
| gptkbp:compatibleWith |
approved for medical use
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:has_higher_potency_than |
gptkb:THC
|
| gptkbp:heldBy |
white crystalline solid
analogue of THC full agonist at cannabinoid receptors |
| https://www.w3.org/2000/01/rdf-schema#label |
CP 55,940
|
| gptkbp:IUPACName |
gptkb:(−)-cis-3-[2-Hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol
|
| gptkbp:legalStatus |
not scheduled internationally
|
| gptkbp:molecularWeight |
372.68 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL214651
3083548 |
| gptkbp:routeOfAdministration |
laboratory use (in vitro, in vivo)
|
| gptkbp:UNII |
6R8T2UT6BE
|
| gptkbp:used_in |
scientific research
|
| gptkbp:bfsParent |
gptkb:CNR1
|
| gptkbp:bfsLayer |
7
|